Projects underway
Drugs
Classification | Seeds Title | Affiliation | Name |
---|---|---|---|
Cancer | Research aiming to develop refractory cancer therapeutics using protein-based drug delivery systems with drug release control function | Graduate School of Agriculture, Osaka Metropolitan University | Takashi INUI |
Cancer | Photodynamic Therapy Reagents Targeting Mitochondria Using Polyamine Tethers | Faculty of Environmental Earth Science, Hokkaido University | Akira ONODA |
Cancer | Development of the new anti-cancer medicine targeting GREB1, a novel Wnt signal-related molecule | 1. Center for Infectious Disease Education and Research, Osaka University 2. Department of Molecular Biology & Biochemistry, Graduate School of Medicine, Osaka University |
Akira KIKUCHI1, Shinji MATSUMOTO2 |
Cancer | Development of new therapeutic methods for hepatocellular carcinoma targeting molecules downstream of PKR | Department of Gastroenterology and Metabology, Graduate School of Medicine, Ehime University | Yoichi HIASA |
Cancer | Research and development of intellectual property for epigenomic drug discovery that dually targets cancer stem cells and cancer immunity | Department of Medical Data Science, Graduate School of Medicine, Osaka University | Hideshi ISHII |
Cancer | Maximizing cost-effectiveness by conjugating modifications for clinical application of innovative nucleic acid drugs | Department of Medical Data Science, Graduate School of Medicine, Osaka University | Hideshi ISHII |
Cancer | Antibody drug discovery against GPCR highly expressing in progressive and bone metastatic prostate cancer | Proteo-Science Center, Ehime University | Yuuki IMAI |
Cancer | Development of antibody-drug conjugates for the treatment of brain tumors | Department of Pathology, Faculty of Medicine, Kindai University | Akihiko ITO |
Cancer | Development of novel therapeutic agents for refractory BRAF mutation-positive colorectal cancer | Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University | Hidekazu TAKAHASHI |
Cancer | Development of Dual-modified Biopharmaceuticals using N-terminal Protein Modification | Faculty of Environmental Earth Science, Hokkaido University | Akira ONODA |
Cancer | Development of anti-cancer drug with immunomodulators | Initiative for Advanced Research, Gunma University | Keisuke NIMURA |
Cancer | Development of anti-cancer drug targetting CKAP4 | Center for Infectious Disease Education and Research, Osaka University | Akira KIKUCHI |
Cancer | Development of innovative antibody therapy against ovarian cancer by controlling lipid metabolism (Acquisition of non-clinical POC for novel antibody therapy using anti-LSR antibody for ovarian cancer) |
Division of Allergy and Rheumatology, Department of Internal Medicine,School of medicine Iwate Medical School | Tetsuji NAKA |
Cancer | Rapid clinical application of specific inhibitors targeting refractory gastrointestinal cancer stem cells | Department of Medical Data Science, Graduate School of Medicine, Osaka University | Hideshi ISHII |
Cancer | Development of Nucleic Acid Lipid Nanoparticles with Anticancer Effects | Research Institute for Microbial Diseases, Osaka University/ Graduate School of Biomedical Sciences, Nagasaki University | Taiki AOSHI |
Cancer | Innovative alpha therapy targeting PSMA for refractory prostate cancer | Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University | Tadashi WATABE |
Cancer | Targeted alpha-ray therapy for refractory thyroid cancer | Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University | Tadashi WATABE |
Cancer | Development of new oral cancer vaccine with the use of intestinal tract immunity | Department of Advanced Medical Science, Graduate School of Science, Technology and Innovation, Kobe University | Toshiro SHIRAKAWA |
Cancer | Development of a new treatment for chemotherapy-resistant triple-negative breast cancer | Department of Advanced Molecular Therapy, Graduate School of Medicine, Osaka University | Yoshiaki TANIYAMA |
Brain and Psychiatry | Development of Improved Treatment Methods for Brain Function-Related Diseases (eating, metabolism, and mental health), Targeting the Vagal Afferent Nerves | Graduate School of Life and Environmental Sciences, Kyoto Prefectural University | Yusaku IWASAKI |
Brain and Psychiatry | Development of therapeutic agents for amyotrophic lateral sclerosis by improving ribosome function | Department of Neurotherapeutics, Graduate School of Medicine, Osaka University | Seiichi NAGANO |
Brain and Psychiatry | Novel drug development for SSRI-resistant depression | Department of Anatomy and Neuroscience Graduate School of Medicine, Osaka Metropolitan University | Makoto KONDO |
Brain and Psychiatry | Development of a novel therapeutic drug for schizophrenia | Graduate School of Biomedical and Health Sciences, Hiroshima University | Yukio AGO |
Brain and Psychiatry | Development of ASOs for multiple system atrophy | Department of Neurology, Graduate school of Medicine, Osaka University | Yasuyoshi KIMURA, Hideki MOCHIZUKI |
Brain and Psychiatry | Sensory medicine: Innovative therapeutics based on the principle of inducing the artificial hibernation / life-protective state by TRPA1 - activating odor molecules | Kansai Medical University | Ko KOBAYAKAWA |
Infectious diseases | Development of Reoviridae virus-based mucosal vaccine vector systems | Research Institute for Microbial Diseases, Osaka University | Takeshi KOBAYASHI |
Infectious diseases | Development of therapeutic strategy for mosquito-borne diseases by targeting mosquito saliva | Department of Microbiology, Graduate School of Medicine, Juntendo University | Tatsuya SUZUKI |
Infectious diseases | Development of a novel antibacterial that targets a molecular chaperone | Tottori University | Tomohiro MIZOBATA |
Infectious diseases | Molecular understanding of the nuclear transport mechanism of flavivirus components and drug discovery | National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) | Yoichi MIYAMOTO |
Infectious diseases | Development of peptide-based universal CTL vaccine for SARS-CoV-2 | Hyogo Medical University | Satoshi ISHIDO |
Infectious diseases | Development of a Novel Anti-African Trypanosomiasis Drug Targeting Cyanide-Resistant Respiration | Gradate School of Medicine, Osaka Metropolitan University | Yasutoshi KIDO |
Infectious diseases | Clinical Development of NPC-BKSE36/CpG Malaria Vaccine | Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University | Toshihiro HORII |
Cardiovascular diseases | Novel therapeutic strategy for cerebral stroke using Npas4-related factors | 1. Graduate school of medicine, Osaka University 2. Graduate school of pharmaceutical sciences, Osaka University |
Taiichi KATAYAMA1, Akio TSUBOI2 |
Cardiovascular diseases | Research for Development of Drug for abdominal aortic aneurysm | Faculty of Agriculture, Kindai University | Nobuhiro ZAIMA |
Cardiovascular diseases | Development of L862, an Innovative Pulmonary Hypertension Treatment Targeting TRPC3/6 | Department of Cardiovascular Medicine Shinshu University School of Medicine | Koichiro KUWAHARA |
Cardiovascular diseases | Development of First-in-class Drug for Bradyarrhythmia (NTC-801F KACh Channel Inhibitor Phase II clinical trial) |
Department of Cardiovascular Medicine, Graduate School of Medicine, Osaka University | Yoshihiro ASANO |
Intractable diseases | Development of new therapeutic agents focused on the liquidliquid phase separation phenomenon of cells | Osaka Metropolitan University | Hidemitsu NAKAJIMA |
Intractable diseases | New drug discovery for Fabry disease | Center for Medical Research & Development, Osaka Medical and Pharmaceutical University | Michio ASAHI |
Intractable diseases | Evaluation of KN3014 a candidate small compound for cryopyrin-associated periodic syndromes (CAPS) in a mouse model | Division of Pathology, Proteo-Science Center, Ehime University | Junya MASUMOTO |
Intractable diseases | Region-specific LOH-inducing applied to HLA region and the sensitive region extracted by GWAS | Genome Editing Research and Development Center, Graduate School of Medicine, Osaka University | Yasuhide YOSHIMURA |
Intractable diseases | Development of inhibitors of protein phosphatases involved in neurodegenerative diseases and investigation of their effects in animal models | The department of Biological Control, RIMD, Osaka University | Shizuka ISHITANI |
Others | Development of single-molecule imaging-based screening technology for drug discovery | Graduate School of Frontier Biosciences, Osaka University | Masahiro UEDA |
Others | Discovering Peptide-based Therapeutics for Neuropathic Pain | Department of Biomedical Engineering Osaka Institute of Technology | Emiko OKUDA-ASHITAKA |
Others | Development of repair therapy for skin barrier function by product lipids of novel lipase | Department of Bio-system Pharmacology, Graduate School of medicine, Osaka University | Ryuichi OHGAKI |
Others | Optimization and functional analysis of active form of IC-2 showing hepatic fibrosis inhibitory effect | Division of Medical Genetics and Regenerative Medicine, Faculty of Medicine, Tottori University | Noriko ITABA |
Others | Establishment of a new strategy for the treatment of functional restoration in skeletal muscle injury by tissue engineering using osteopontinederived SVVYGLR peptide | Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Osaka University | Susumu TANAKA |
Others | A new anti-inflammatory drug that utilizes the active site of an endogenous NFkB direct inhibitory protein | Department of Obstetrics & Gynecology, Graduate School of Medicine, Osaka University | Kazuki OKAMOTO |
Others | Development of prophylaxis of aspiration pneumonia by aural stimulation with capsaicin ointment | Department of Otolaryngology, University of Tokushima School of Medicine | Yoshiaki KITAMURA |
Medical devices
Regenerative medicine
Diagnostics
Seeds Title | Affiliation | Name | |
---|---|---|---|
Identification of unknown skin autoantigen of autoimmune bullous disease aiming for patent application and development of comprehensive aotoantibody measurement system | Belongs Department of Dermatology, Graduate School of Medicine, Osaka Metropolitan University, and AIBD LAB Co., Ltd. | Takashi HASHIMOTO | |
Development of a New Method for Detection of Effects Induced by Maternal Immune Activation | Department of Neuroscience and Cell Biology, Graduate School of Medicine, Osaka Uiversity | Shoichi SHIMADA | |
Establishment and clinical application of rapid and highly accurate identification method for nontuberculous mycobacteriosis by real-time core genome analysis | Immunology Frontier Research Center, Osaka University | Kiyoharu FUKUSHIMA | |
Rapid and“ in-situ” determination method of polyamines | Kyoto Prefectural University, Graduate School of Life and Environmental Sciences | Kazunori TSUBAKI | |
Development of pathological periostin measurement device | Department of Advanced Molecular Therapy, Graduate School of Medicine, Osaka University | Yoshiaki TANIYAMA | |
Development of a diagnostic method for patients with chronic inflammatory disease using analysis of sugar chains of IgGs | Department of Biopathological Information Science, Graduate School of Medicine, Osaka University | Eiji MIYOSHI | |
Prognosis biomarkers that can discriminate early-stage pancreatic cancer patients with worse prognosis prior to surgery | Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi University | Keisuke TANIUCHI | |
Development of automatic rapid diagnosis for cervical lymph node metastasis of oral cancer | Department of Oral and Maxillofacial Surgery, Ehime University Graduate School of Medicine | Koh-ichi NAKASHIRO |